Transcript · English → Japanese
FDA Monopoly and Pharmaceutical Funding
問題は ええと FDAが
独占していることです 門番の役をしています
はい
彼らがあなたに求めることは 莫大な資金と資源を必要とします
―
はい
それを持てるのは大手製薬会社—
はい
はい
それに バイオ企業も
それに バイオ企業も
大手製薬会社も 長期的に利益が出るものにしか
資金を出したがりません
だから治療法は商売になりません
「これで治る」というものは あまり好まれません
ええと もし ずっと
飲み続けなければならない
薬を開発したなら
彼らはずっと乗り気になります
そう そう そう
だから—
でも 私たちには分かりません
問題を解決するものを探そうと—
単に治すだけではなく
単に治すだけではなく
End of transcript · 152 words · machine translated
Original transcript (English)
The, the issue is that, um, uh, that, uh, the FDA has a monopoly, right? They act as the gatekeeper. Yes. And really what they're asking you to do are things that require an incredible amount of money and resources-
Yes ... which only really big pharmaceuticals- Yes ... are very well-healed biotech companies have.
And, um, biotech, big pharma, they often only wanna fund things that are going to have longevity. So cures are not good business. So things that are like, "Oh, this fixes it," no so, not so good.
Um, if, if you came up with something where they'd have to, like, constantly be taking this drug for life, they're a lot more excited about that. Right, right, right.
So- Well, and we don't know ... try to find the things that solve it- Yeah, yeah ... without just curing.
